Januvia off to good start, data shows

November 28 2006

Merck’s new first-in-class diabetes drug Januvia is off to a strong start, according to data from ImpactRx, a market research ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.